Stroke/Cerebrovascular Disease News

• Alert FDA Approves New Drug, Sotagliflozin, for Heart Failure Sotagliflozin, a novel inhibitor of both SGLT 1 and 2, enters the US market with indications for preventing CV events, especially heart failure hospitalization and acute exacerbations.
  FDA Approvals, May 26, 2023
• ESOC 2023 AI Improves Stroke Recognition in Emergency Calls An artificial intelligence tool outperformed human call handlers in recognizing patients with stroke from calls to the emergency services in a new study.
  Medscape Medical News, May 26, 2023
• Plant-Based Diet Tied to Healthier Blood Lipid Levels 'If people start eating vegetarian or vegan diets from an early age, the potential for reducing the risk of cardiovascular disease caused by blocked arteries is substantial,' says study author.
  Medscape Medical News, May 26, 2023
• Real-World Data Validate ESC Risk Model in NSTE-ACS A real-world study has potentially validated a risk model put forward by the European Society of Cardiology for management of acute coronary syndromes without persistent ST-segment elevation.
  MDedge News, May 25, 2023
• ESOC 2023 Care Bundle Improves Outcome in ICH: INTERACT3 A combination of simple interventions for patients with acute hemorrhagic stroke has been shown to significantly improve the chances of survival without major disability.
  Medscape Medical News, May 25, 2023
• ESOC 2023 Earlier Anticoagulation Safe in Stroke With AF: ELAN Patients presenting with ischemic stroke found to have atrial fibrillation can safely start a direct oral anticoagulant much earlier than starting occurs in current practice, a new study suggests.
  Medscape Medical News, May 24, 2023
• HRS 2023 Losing Weight May Bolster AF Ablation's Chances for Success 'We're talking about a moderate amount,' said a researcher when discussing how much weight loss before ablation of atrial fibrillation may improve the procedure's chances for success.
  Medscape Medical News, May 22, 2023
• SPARTAN 2023 TNF, JAK Inhibitors' CV Safety Compared in PsA, AxSpA JAK inhibitors were not associated with higher risk of myocardial infarction or stroke and venous thromboembolism, compared with TNF-inhibitor users, in a small study.
  MDedge News, May 19, 2023
• EuroPCR 2023 Evidence of TAVR Benefit Extends to Cardiogenic Shock Patients in cardiogenic shock should not be excluded from transcatheter aortic valve replacement, despite some early adverse event risk, new registry data suggest.
  MDedge News, May 18, 2023
• EuroPCR 2023 Redo TAVR Outcomes Rival First Intervention A large transcatheter aortic valve transplant (TAVR) database shows a second procedure performs about as well as native TAVR.
  MDedge News, May 17, 2023
• AHA Urges Action Against Racial Inequities in Stroke Care Stroke care is rife with inequities, a new AHA statement says, and fixing them will require more research into issues such as structural racism and other 'upstream' social factors.
  Medscape Medical News, May 16, 2023
• Novel Insights on Takotsubo Could Lead to New Therapies New mechanisms underlying this condition, often dubbed "broken heart syndrome," have been suggested from hemodynamic studies, which could lead to new treatment strategies.
  Medscape Medical News, May 16, 2023
• Alert FDA OKs New Drug for Hot Flashes The first-in-class approval of fezolinetant (Veozah) is for treatment of moderate to severe vasomotor symptoms associated with menopause.
  Medscape Medical News, May 12, 2023
• Alert FDA OKs New Drug for Fabry Disease Pegunigalsidase alfa (Elfabrio) is an intravenously administered enzyme replacement therapy to treat adults with confirmed Fabry disease.
  Medscape Medical News, May 11, 2023
• AANS 2023 Clot Evacuation After ICH Tied to Better Outcome: ENRICH ENRICH trial results comparing minimally invasive trans-sulcal parafascicular surgery (MIPS) to standard care are encouraging but need replication in a larger trial, one outside expert says.
  Medscape Medical News, May 10, 2023
• EHRA 2023 Surprisingly More NSVT Using Extended ECG Monitoring in HCM With implications for sudden-death risk assessment, 30-day compared to 24-hour monitoring may detect far more clinically important arrhythmias in patients with hypertrophic cardiomyopathy.
  Medscape Medical News, May 09, 2023
• Metformin Ups Myocardial Perfusion and Survival in T2D Treatment of adults with type 2 diabetes with metformin significantly linked with better myocardial perfusion and improved survival in a multicenter, observational study with 572 subjects.
  First Look, May 09, 2023
• AHA Flags Differing CVD Risk in Asian American Subgroups Examining Asian American subgroups separately is 'crucial' to understanding distinctions among them and how these differences affect their risk of type 2 diabetes and CVD, a new AHA statement says.
  Medscape Medical News, May 08, 2023
• High Follistatin Predicts Poor Cardiometabolic Outcomes Elevated plasma levels of the liver protein follistatin may predict incident chronic kidney disease and other adverse outcomes, independent of diabetes, based on 23-year follow-up of a Swedish cohort.
  First Look, May 08, 2023
• AAN 2023 Stroke Scale Cutoff Might Not Be Ideal Guide 'When you are discussing when to perform CTA in patients with a low NIHSS score, you are discussing the majority of patients,' said Dr Theresa Sevilis regional medical director for TeleSpecialists.
  MDedge News, May 05, 2023